Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.

Margaret McGladrey, Jordan Kelsch, Michelle R Lofwall, Laura C Fanucchi, Sharon L Walsh, Carrie B Oser
{"title":"Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.","authors":"Margaret McGladrey, Jordan Kelsch, Michelle R Lofwall, Laura C Fanucchi, Sharon L Walsh, Carrie B Oser","doi":"10.1089/jchc.23.08.0065","DOIUrl":null,"url":null,"abstract":"<p><p>In a case example from the Kentucky HEALing Communities Study, extensive resources were deployed to address structural barriers and facilitate the provision of medication for opioid use disorder (OUD) in an urban county jail. However, implementation was unsuccessful, and this case example emphasizes the importance of including evidence-based medication for OUD (MOUD) treatment in the scope of work of jails' contracted medical providers. The privatization of correctional health care services allows local governments with opioid abatement funds to incorporate requirements into medical provider contracts to screen all people entering jails for OUD and to offer MOUD at intake, throughout incarceration, and upon release to everyone for whom it is clinically indicated. We provide sample contractual language that can be added to requests for medical provider proposals to help drive the private correctional health care market toward integrating MOUD treatment into their standard of care. This approach also could expedite efforts to scale up broad MOUD access across U.S. jails through sharing of workflows and best practices among the small group of national correctional health care companies contracted with jails in states with broad mandates, such as Massachusetts. Clinical Trial Registration: NCT04111939.</p>","PeriodicalId":73693,"journal":{"name":"Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","volume":" ","pages":"3-6"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071097/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of correctional health care : the official journal of the National Commission on Correctional Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/jchc.23.08.0065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In a case example from the Kentucky HEALing Communities Study, extensive resources were deployed to address structural barriers and facilitate the provision of medication for opioid use disorder (OUD) in an urban county jail. However, implementation was unsuccessful, and this case example emphasizes the importance of including evidence-based medication for OUD (MOUD) treatment in the scope of work of jails' contracted medical providers. The privatization of correctional health care services allows local governments with opioid abatement funds to incorporate requirements into medical provider contracts to screen all people entering jails for OUD and to offer MOUD at intake, throughout incarceration, and upon release to everyone for whom it is clinically indicated. We provide sample contractual language that can be added to requests for medical provider proposals to help drive the private correctional health care market toward integrating MOUD treatment into their standard of care. This approach also could expedite efforts to scale up broad MOUD access across U.S. jails through sharing of workflows and best practices among the small group of national correctional health care companies contracted with jails in states with broad mandates, such as Massachusetts. Clinical Trial Registration: NCT04111939.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以书面形式提供:如何在监禁期间提供治疗阿片类药物使用障碍的药物。
在肯塔基州 "健康社区研究"(HEALing Communities Study)的一个案例中,为解决结构性障碍并促进在城市县监狱中提供阿片类药物使用障碍(OUD)药物治疗,部署了大量资源。然而,实施并不成功,这个案例强调了将循证药物治疗阿片类药物使用障碍(MOUD)纳入监狱签约医疗服务提供者工作范围的重要性。惩教医疗服务的私有化使得地方政府可以利用阿片类药物减排基金,在医疗服务提供商的合同中加入要求,对所有进入监狱的人进行 OUD 筛查,并在入狱时、整个监禁期间以及释放后向所有有临床指征的人提供 MOUD 治疗。我们提供了合同措辞样本,可以将其添加到医疗服务提供商的提案请求中,以帮助推动私营惩教医疗市场将 MOUD 治疗纳入其护理标准。通过与马萨诸塞州等具有广泛授权的州的监狱签订合同的一小部分全国性惩教医疗保健公司之间分享工作流程和最佳实践,这种方法还可以加快在美国监狱中推广MOUD治疗的步伐。临床试验注册:NCT04111939.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Conducting Grief Support Groups in Prison: A Pragmatic Feasibility and Impact Study. Characterization of Dermatologic Disease and Challenges in Care of Incarcerated Patients. The Development, Delivery, Content, and Impact of Nutrition Education in Prisons: A Systematic Review. An Assessment of the Nutritional Profile of Foods Accessible to Incarcerated Males in Alabama. Resident Experiences at a Community Hospital Caring for Patients Who Are Incarcerated.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1